U.S. Healthtech Stock News

NasdaqGS:POWI
NasdaqGS:POWISemiconductor

Assessing Power Integrations (POWI) Valuation After A Sharp Short Term Share Price Rally

Recent performance snapshot for Power Integrations stock Power Integrations (POWI) has drawn fresh attention after a strong recent share price move, with the stock up about 33% over the past month and roughly 52% over the past 3 months. See our latest analysis for Power Integrations. Even after the sharp 33% 1 month share price return and 52% 3 month share price return, Power Integrations’ longer term picture is mixed, with a 1 year total shareholder return of 32% but a 3 year total...
NasdaqCM:VRDN
NasdaqCM:VRDNBiotechs

How Strong REVEAL-2 Data and Fresh Capital Raises Could Shape Viridian Therapeutics (VRDN) Investors

Viridian Therapeutics recently reported positive topline results from its REVEAL-2 phase 3 trial, showing that elegrobart significantly improved multiple measures of chronic thyroid eye disease and was generally well tolerated, while also completing US$125,000,014 and US$225,000,000 capital raises through common stock and convertible notes offerings. The REVEAL-2 data position elegrobart as a potential at-home subcutaneous treatment for both active and chronic thyroid eye disease,...
NYSE:CMS
NYSE:CMSIntegrated Utilities

A Look At CMS Energy (CMS) Valuation As Shares Trade Near Analyst And DCF Estimates

Why CMS Energy (CMS) is on investors’ radar today CMS Energy (CMS) has drawn fresh attention after recent trading left the stock at a last close of US$72.81, with performance over the past month and past 3 months giving investors more to think about. See our latest analysis for CMS Energy. While the share price has eased in the short term, including a 1-month share price return of down 7.19%, the year-to-date share price return of 3.39% sits alongside a 1-year total shareholder return of...
NYSE:AROC
NYSE:AROCEnergy Services

Is It Too Late To Consider Archrock (AROC) After Its Recent Strong Share Price Run

Investors may be wondering whether Archrock's current share price reflects its true worth, or if the stock is starting to look stretched after a strong run. The stock finished the last session at US$36.80, with returns of 38.2% year to date and 47.2% over the past 12 months. However, it has fallen 5.9% over the last week and is roughly flat over the past month with a 0.9% gain. Recent coverage has focused on Archrock's position in energy infrastructure and how investors are reacting to...
NYSE:BXMT
NYSE:BXMTMortgage REITs

A Look At Blackstone Mortgage Trust (BXMT) Valuation As Shares Trade Below Narrative Fair Value

Recent performance snapshot Blackstone Mortgage Trust (BXMT) has drawn investor attention after a mixed recent performance, with the stock last closing at US$18.43 and sitting on a market cap of about US$3.1b. Over the past month the stock is down about 6.8%, and over the past 3 months it is down about 6.7%. Year to date it is down about 5.4%, while the 1 year total return is about 4.3%. See our latest analysis for Blackstone Mortgage Trust. For investors, the picture is one of fading near...
NYSE:AIR
NYSE:AIRAerospace & Defense

Assessing AAR (AIR) Valuation After A Sharp Pullback And Conflicting Fair Value Signals

AAR (AIR) has come into focus after recent trading, with the stock now around $107.47 and showing mixed performance, up over the past year but down over the past month and the past 3 months. See our latest analysis for AAR. For now, momentum has cooled, with the share price down 9.5% over the past week and 13.2% over the past month. This is despite the year to date share price return of 27.3% and 1 year total shareholder return of 76.0%, which point to a much stronger longer term picture. If...
NasdaqCM:SBET
NasdaqCM:SBETHospitality

Sharplink Rethinks ETH Treasury With Galaxy Onchain Yield Fund Partnership

Sharplink (NasdaqCM:SBET) has entered a partnership with Galaxy Digital to launch the Galaxy Sharplink Onchain Yield Fund. The fund is designed to manage Sharplink's Ethereum treasury with an institutional-grade, onchain yield approach instead of passive holding. This marks a shift in how the company handles its crypto assets, focusing on risk managed yield while maintaining Ethereum exposure. Sharplink is drawing attention by rethinking how its Ethereum holdings are used, at a time when...
NYSE:STUB
NYSE:STUBEntertainment

Assessing StubHub Holdings (STUB) Valuation After Recent Share Price Weakness And Rebound

StubHub Holdings stock moves: recent returns and fundamentals in focus StubHub Holdings (STUB) has drawn fresh attention after a mixed stretch in the stock, with a gain of 2.7% over the past day, a rise of 14.8% over the past month, but a decline of 14.3% over the past 3 months. At a last close of US$7.52 and a market value of about US$2.7b, the company operates a global ticketing marketplace under the StubHub and viagogo brands, with annual revenue of US$1,745.2 million and a reported net...
NYSE:GPOR
NYSE:GPOROil and Gas

Is Strong Q1 Results And New CEO Appointment Altering The Investment Case For Gulfport Energy (GPOR)?

Gulfport Energy reported first-quarter 2026 results with revenue of US$437.53 million and net income of US$165.82 million, alongside reaffirmed full-year production guidance and completion of a large share repurchase program. The company also named former Expand Energy chief Domenic “Nick” Dell’Osso, Jr. as its incoming president and CEO, signaling continued emphasis on operational discipline and shareholder-focused capital allocation. We’ll now examine how Gulfport’s strong earnings jump...
NYSE:CE
NYSE:CEChemicals

A Look At Celanese (CE) Valuation After A Strong Year To Date Rally And Recent Pullback

Recent performance snapshot for Celanese (CE) Celanese (CE) has caught investor attention after a mixed recent run, with the stock roughly flat over the past 3 months, down about 12% over the past month, and up around 42% year to date. See our latest analysis for Celanese. Despite a recent 12% 1 month share price decline and softer 7 day performance, Celanese still shows stronger momentum over a longer horizon. A 42.24% year to date share price return and a 14.48% 1 year total shareholder...
NYSE:FDP
NYSE:FDPFood

Fresh Del Monte Conference Appearance Puts Profit Pressures And Capital Returns In Focus

Fresh Del Monte Produce (NYSE:FDP) plans to participate in the TD Cowen Future of the Consumer Conference. Senior management is scheduled for a fireside chat and one-on-one meetings with investors during the event. The conference appearance offers the company a platform to outline priorities and engage directly with the investment community. For investors tracking NYSE:FDP, this conference comes with the stock recently closing at $35.53 and posting a gain of 14.8% over the past year. Over...
NYSE:LCII
NYSE:LCIIAuto Components

Is It Time To Reassess LCI Industries (LCII) After Its Recent Share Price Pullback?

Investors may be wondering whether LCI Industries at around US$110.96 is offering good value right now, or if the easy gains are already behind it. The stock has pulled back recently, with the share price down about 5.1% over the past week and 9.9% over the past month, even though the 1 year return sits at 29.7%. Recent headlines have focused on LCI Industries as investors reassess auto components stocks and their sensitivity to consumer demand and capital spending. This shifting attention...
NYSE:ACI
NYSE:ACIConsumer Retailing

Executive Share Sale and Legal Strains Might Change The Case For Investing In Albertsons Companies (ACI)

Earlier in May 2026, Albertsons Companies disclosed that Senior Vice President and Chief Accounting Officer Robert Bruce Larson sold 44,363 Class A shares at around US$16.01–US$16.03 each, leaving him with 53,269 shares, while the retailer also confronted lawsuits, a failed merger and intensifying online grocery competition. These developments, alongside weaker fresh produce sales and a growing dependence on the pharmacy division following an opioid-related settlement, highlight mounting...
NYSE:ZETA
NYSE:ZETASoftware

Assessing Zeta Global Holdings (ZETA) Valuation After Mixed Short Term Returns And Strong Three Year Gains

Zeta Global Holdings (ZETA) has experienced mixed short-term returns, with a decline over the past week and day, but gains over the past month and past 3 months shaping recent performance. See our latest analysis for Zeta Global Holdings. At a share price of $16.04, Zeta Global Holdings has seen short term share price pressure with its year to date share price return down 19.44%, yet longer term momentum shows through a 95.13% total shareholder return over three years. If Zeta’s recent swings...
NasdaqGM:SMMT
NasdaqGM:SMMTBiotechs

A Look At Summit Therapeutics (SMMT) Valuation After HARMONi-3 Downgrade And Wider Quarterly Loss

What triggered the latest focus on Summit Therapeutics? The recent spotlight on Summit Therapeutics (SMMT) is tied to two developments: a downgrade by H.C. Wainwright following weaker interim HARMONi-3 trial signals, and first quarter results showing a net loss of US$189.42 million. See our latest analysis for Summit Therapeutics. Despite the weaker interim HARMONi-3 update and wider first quarter loss, Summit Therapeutics’ share price has slipped 6.19% over the past month but remains up...
NYSE:UAMY
NYSE:UAMYMetals and Mining

Does United States Antimony’s (UAMY) Compounding Track Record Reveal a Durable Edge or One-Off Success?

Earlier this month, United States Antimony announced it would release its Q1 2026 results on May 14 and host an earnings call the same day to update investors on its operations. Investor attention has recently centered on a report highlighting United States Antimony’s very large decade-long compounded return, underscoring how long-term holding can materially reshape investment outcomes. We’ll now examine how this renewed focus on United States Antimony’s long-term compounding record may...
NYSE:NU
NYSE:NUBanks

Nu Holdings (NU) Is Down 11.5% After Strong Results And U.S. Charter Approval - What's Changed

Nu Holdings, Latin America's largest digital bank, reported strong full-year results with very large revenue growth and a 33% Q4 return on equity, and also secured conditional approval from the U.S. OCC for a national bank charter. With markets now focused on its Q1 2026 earnings released after the bell on May 14, attention is turning to how Nu’s rapid customer expansion and regional penetration will influence its premium valuation and growth ambitions beyond Latin America. We’ll now examine...
NasdaqGS:ETOR
NasdaqGS:ETORCapital Markets

Assessing eToro Group (NasdaqGS:ETOR) Valuation After Recent Share Price Strength

Recent performance triggers fresh interest in eToro Group stock eToro Group (NasdaqGS:ETOR) has drawn fresh attention after a sharp move in its share price, with the stock up 9.8% over the past day and 6.9% over the past week. That short term strength sits alongside a 24.0% gain over the past month and 54.4% over the past 3 months. This has prompted investors to reassess the US$2.99b online trading platform and its current valuation. See our latest analysis for eToro Group. At a share price...
NYSE:AGRO
NYSE:AGROFood

Adecoagro Q1 2026 Shows Fertilizer Powering Growth And Faster Deleveraging

Adecoagro (NYSE:AGRO) reported strong Q1 2026 results with its fertilizer division emerging as the main growth driver. The fertilizers segment, strengthened by the Profertil acquisition, delivered record profitability supported by higher urea prices and improved operational reliability. The company outlined an accelerated deleveraging path and confirmed a focus on sustaining dividends within a new three segment structure. Adecoagro, trading at $13.65, is coming off a strong run, with the...
NYSE:SR
NYSE:SRGas Utilities

Assessing Spire (SR) Valuation After New Analyst Coverage Insider Buying And Profitable Results

Why Spire (SR) is back on investors’ radar Spire (SR) has drawn fresh attention after Wells Fargo began coverage alongside increased director share purchases, all coming shortly after the company reported profitable second quarter and six month 2026 results. See our latest analysis for Spire. At a share price of $85.56, Spire has eased in the short term, with the share price return down over the past month and quarter. However, the 1 year and multi year total shareholder returns remain...
NYSE:QGEN
NYSE:QGENLife Sciences

Does Qiagen's (QGEN) Bigger Dividend and Governance Shift Signal a New Capital Allocation Playbook?

In May 2026, QIAGEN N.V. proposed a 40% increase in its annual cash dividend to US$0.35 per share for approval at the June 24, 2026 Annual General Meeting, while also announcing plans to appoint co-founder and former CEO Dr. Metin Colpan as Honorary Chairman after he steps down from the Supervisory Board. The combination of a higher dividend, expanded shareholder return authorizations, and ongoing Supervisory Board renewal underscores how QIAGEN is pairing governance refreshment with a...
NYSE:DINO
NYSE:DINOOil and Gas

How CEO Turnover Amid Robust Buybacks And Dividends At HF Sinclair (DINO) Has Changed Its Investment Story

HF Sinclair recently reported first-quarter 2026 results, with sales of US$7,123 million and net income of US$648 million, while also completing a US$616.56 million share repurchase program and declaring a regular US$0.50 per-share dividend payable on June 2, 2026. These solid capital returns came as the company confirmed the past departure of CEO Timothy Go and ongoing interim leadership under Chairperson Franklin Myers, keeping corporate governance and succession firmly in focus for...
NYSE:FBP
NYSE:FBPBanks

Assessing First BanCorp (FBP) Valuation After Recent Share Price Pullback

Why First BanCorp (FBP) is on investors’ radar today First BanCorp (FBP) came into focus after recent trading left the stock modestly lower over the past week, even as its year to date and 1 year total returns remain positive. See our latest analysis for First BanCorp. The recent 1 day share price decline of 1.16% and 7 day share price decline of 4.90% come after a period of steadier gains. A year to date share price return of 10.48% and a 3 year total shareholder return of 123.09% point to...
NYSE:CAH
NYSE:CAHHealthcare

Cardinal Health (CAH) Valuation Check As Income Drop And Goodwill Impairment Pressure The Story

Why Cardinal Health (CAH) is back in focus after its latest quarter Cardinal Health (CAH) has moved back onto investors’ radar after its third quarter results showed a year-over-year decline in net income and a sizeable goodwill impairment tied to its Navista and ION unit. These profit and impairment headlines came alongside large pharmaceutical distribution sales, ongoing share repurchases, and an updated dividend. Together, they provide several angles to reassess how the stock fits into a...